University of California San Francisco

Publications

  1. Advanced WIfI Stage is Associated with Poor Outcomes in the BEST-CLI Trial.
    2024 | PubMed
  2. Impact of Skin Closure with Staples Versus Sutures on Perioperative Outcomes Following Lower Extremity Bypass Surgery.
    2024 | PubMed
  3. The Impact of pH on the Piezoelectric Properties of Dentin in Root Canal Treated Teeth: Implications for Dental Materials and Oral Health.
    2024 | PubMed
  4. Better limb staging in chronic limb-threatening ischemia: Why it matters.
    2024 | PubMed
  5. A Novel Preoperative Risk Score to Identify Patients at High Risk for Nonhome Discharge after Elective Open Abdominal Aortic Aneurysm Repair.
    2024 | PubMed
  6. The Impact of Diabetes Mellitus on the Outcomes of Revascularization for Chronic Limb-Threatening Ischemia in the BEST-CLI trial.
    2024 | PubMed
  7. Prosthetic Conduits have Worse Outcomes compared to Great Saphenous Vein Conduits in Femoropopliteal and Infrapopliteal Bypass in Patients with Chronic Limb Threatening Ischemia.
    2024 | PubMed
  8. Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.
    2024 | PubMed
  9. Dynamic changes in proresolving lipid mediators and their receptors following acute vascular injury in male rats.
    2024 | PubMed
  10. Early Opioid Use and Postoperative Delirium Following Open Abdominal Aortic Aneurysm Repair.
    2024 | PubMed
  11. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.
    2024 | PubMed
  12. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.
    2024 | PubMed
  13. Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes.
    2024 | PubMed
  14. Infrapopliteal Endovascular Interventions for Claudication Are Associated with Poor Long-Term Outcomes in Medicare-Matched Registry Patients.
    2024 | PubMed
  15. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice.
    2024 | PubMed
  16. The importance of optimal medical therapy in patients undergoing lower extremity bypass.
    2024 | PubMed
  17. Fixing a Hole: a retrospective cohort study evaluating HAV, HBV, tetanus screening, and vaccination during hospitalization in persons who use substances.
    2024 | PubMed
  18. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial.
    2024 | PubMed
  19. Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization.
    2024 | PubMed
  20. Appropriateness of Care Measures: A Novel Approach to Quality.
    2024 | PubMed
  21. The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia.
    2024 | PubMed
  22. Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program.
    2024 | PubMed
  23. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.
    2024 | PubMed
  24. Exploring the impact of type II diabetes mellitus on voice quality.
    2024 | PubMed
  25. Predictors of amputation-free survival and wound healing after infrainguinal bypass with alternative conduits.
    2024 | PubMed
  26. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally.
    2024 | PubMed
  27. Demonstrating Agreement between Radio and Fluorescence Measurements of the Depth of Maximum of Extensive Air Showers at the Pierre Auger Observatory.
    2024 | PubMed
  28. Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.
    2023 | PubMed
  29. Risk factors and associated outcomes of postoperative delirium after open abdominal aortic aneurysm repair.
    2023 | PubMed
  30. Development and Validation of a Novel Preoperative Risk Score to Identify Patients at Risk for Nonhome Discharge after Elective Endovascular Aortic Aneurysm Repair (EVAR).
    2023 | PubMed
  31. Decreasing prevalence of centers meeting the Society for Vascular Surgery abdominal aortic aneurysm guidelines in the United States.
    2023 | PubMed
  32. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries.
    2023 | PubMed
  33. Editor's Choice - The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer.
    2023 | PubMed
  34. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer.
    2023 | PubMed
  35. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer.
    2023 | PubMed
  36. Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review.
    2023 | PubMed
  37. Apples and oranges? A comparison of BEST-CLI to BASIL-2.
    2023 | PubMed
  38. Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review.
    2023 | PubMed
  39. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review.
    2023 | PubMed
  40. Effects of Diabetes on Elemental Levels and Nanostructure of Root Canal Dentin.
    2023 | PubMed
  41. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial.
    2023 | PubMed
  42. Transcatheter Arterialization of Veins in Chronic Limb-Threatening Ischemia.
    2023 | PubMed
  43. Baseline modern medical management in the BEST-CLI trial.
    2023 | PubMed
  44. Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemia.
    2023 | PubMed
  45. Iliac artery calcification score stratifies mortality risk estimation in patients with chronic limb-threatening ischemia undergoing revascularization.
    2023 | PubMed
  46. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    2023 | PubMed
  47. Lower-extremity pressure, staging, and grading thresholds to identify chronic limb-threatening ischemia.
    2023 | PubMed
  48. Vascular health and the health of vascular surgery-2021 Western Vascular Society Presidential Address.
    2023 | PubMed
  49. Structured discharge documentation reduces sex-based disparities in statin prescription in vascular surgery patients.
    2023 | PubMed
  50. Cognitive Impairment is Common in a Veterans Affairs Population with Peripheral Arterial Disease.
    2022 | PubMed
  51. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia.
    2022 | PubMed
  52. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    2022 | PubMed
  53. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
    2022 | PubMed
  54. Reply.
    2022 | PubMed
  55. Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trial.
    2022 | PubMed
  56. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    2022 | PubMed
  57. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention.
    2022 | PubMed
  58. Screening for co-infections in patients with substance use disorders and severe bacterial infections.
    2022 | PubMed
  59. Evaluation of the Global Limb Anatomic Staging System in patients with chronic limb-threatening ischemia undergoing endovascular intervention for femoropopliteal disease.
    2022 | PubMed
  60. Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population.
    2022 | PubMed
  61. Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease.
    2022 | PubMed
  62. Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference.
    2022 | PubMed
  63. Association of Intraoperative and Perioperative Transfusions with Postoperative Cardiovascular Events and Mortality After Infrainguinal Revascularization.
    2022 | PubMed
  64. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia.
    2022 | PubMed
  65. Clinical Predictors and Outcomes Associated with Postoperative Delirium Following Infrainguinal Bypass Surgery.
    2022 | PubMed
  66. Searching for a New Parameter in the Healing of Tibia Pilon Fractures: Fracture Area Measurement.
    2022 | PubMed
  67. Capturing the complexity of open abdominal aortic surgery in the endovascular era.
    2022 | PubMed
  68. Factors associated with lower preoperative quality of life in patients with chronic limb-threatening ischemia in the BEST-CLI trial.
    2022 | PubMed
  69. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    2022 | PubMed
  70. Society for Vascular Surgery appropriate use criteria for management of intermittent claudication.
    2022 | PubMed
  71. Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population.
    2022 | PubMed
  72. Analysis of a Machine Learning-Based Risk Stratification Scheme for Chronic Limb-Threatening Ischemia.
    2022 | PubMed
  73. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury.
    2022 | PubMed
  74. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.
    2022 | PubMed
  75. Patient-Reported Outcome Measures in Symptomatic, Non-Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review.
    2021 | PubMed
  76. Endovascular treatment of high-risk peripheral vascular occlusive lesions: a review of current evidence and emerging applications of intravascular lithotripsy, atherectomy, and paclitaxel-coated devices.
    2021 | PubMed
  77. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies.
    2021 | PubMed
  78. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia.
    2021 | PubMed
  79. A critical appraisal of registry-based objective performance goals in peripheral arterial disease.
    2021 | PubMed
  80. Feasibility of Photo-Optical Transcutaneous Oxygen Tension Measurement During Revascularization of the Lower Extremity.
    2021 | PubMed
  81. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
    2021 | PubMed
  82. The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement.
    2021 | PubMed
  83. Invasive treatment of claudication: Time for better measures and better controls.
    2021 | PubMed
  84. Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia.
    2021 | PubMed
  85. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.
    2021 | PubMed
  86. Understanding value and patient complexity among common inpatient vascular surgery procedures.
    2021 | PubMed
  87. Closure device use for common femoral artery antegrade access is higher risk than retrograde access.
    2021 | PubMed
  88. Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center.
    2021 | PubMed
  89. A Limb is a Peninsula- and No Clinician is an Island: Introducing the American Limb Preservation Society (ALPS).
    2021 | PubMed
  90. The Significance of the Global Vascular Guidelines for Podiatrists: Answers to Key Questions in the Diagnosis and Management of the Threatened Limb.
    2021 | PubMed
  91. The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.
    2021 | PubMed
  92. Depression Predicts Non-Home Discharge After Abdominal Aortic Aneurysm Repair.
    2021 | PubMed
  93. Patients with depression are less likely to go home after critical limb revascularization.
    2020 | PubMed
  94. Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines.
    2020 | PubMed
  95. Reply.
    2020 | PubMed
  96. A novel preoperative risk score for nonhome discharge after elective thoracic endovascular aortic repair.
    2020 | PubMed
  97. Consensus-based perioperative protocols during the COVID-19 pandemic.
    2020 | PubMed
  98. Implementing global chronic limb-threatening ischemia guidelines in clinical practice: Utility of the Society for Vascular Surgery Threatened Limb Classification System (WIfI).
    2020 | PubMed
  99. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.
    2020 | PubMed
  100. Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program.
    2020 | PubMed
  101. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    2020 | PubMed
  102. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
    2020 | PubMed
  103. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy.
    2020 | PubMed
  104. Living in a Food Desert is Associated with 30-day Readmission after Revascularization for Chronic Limb-Threatening Ischemia.
    2020 | PubMed
  105. Corrigendum to "Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia" [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1-109>].
    2020 | PubMed
  106. Increased Reintervention After Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women.
    2020 | PubMed
  107. Clinical Effectiveness and Resource Utilization of Surgery versus Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    2020 | PubMed
  108. Patient complexity by surgical specialty does not correlate with work relative value units.
    2020 | PubMed
  109. Meaningful change in 6-minute walk in people with peripheral artery disease.
    2020 | PubMed
  110. Natural history of acute pediatric iliofemoral artery thrombosis treated with anticoagulation.
    2020 | PubMed
  111. External validation of the Vascular Quality Initiative prediction model for survival in no-option chronic limb-threatening ischemia patients.
    2020 | PubMed
  112. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer.
    2020 | PubMed
  113. Antegrade common femoral artery closure device use is associated with decreased complications.
    2020 | PubMed
  114. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.
    2020 | PubMed
  115. Where do We Go to in the Treatment of Acute Limb Ischaemia?
    2020 | PubMed
  116. Appropriate use of revascularization for claudication.
    2020 | PubMed
  117. Reply.
    2020 | PubMed
  118. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease.
    2019 | PubMed
  119. Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109].
    2019 | PubMed
  120. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
    2019 | PubMed
  121. Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia.
    2019 | PubMed
  122. Risk score for nonhome discharge after lower extremity bypass.
    2019 | PubMed
  123. Building a global alliance in vascular surgery.
    2019 | PubMed
  124. Building a Global Alliance in Vascular Surgery.
    2019 | PubMed
  125. Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease.
    2019 | PubMed
  126. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    2019 | PubMed
  127. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
    2019 | PubMed
  128. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    2019 | PubMed
  129. Global vascular guidelines on the management of chronic limb-threatening ischemia.
    2019 | PubMed
  130. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    2019 | PubMed
  131. Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization.
    2019 | PubMed
  132. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
    2019 | PubMed
  133. Invited commentary.
    2018 | PubMed
  134. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    2018 | PubMed
  135. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    2018 | PubMed
  136. Pro-resolving lipid mediators in vascular disease.
    2018 | PubMed
  137. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
    2018 | PubMed
  138. Interventions for lower extremity peripheral artery disease.
    2018 | PubMed
  139. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    2018 | PubMed
  140. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
    2018 | PubMed
  141. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial.
    2018 | PubMed
  142. Data, guidelines, and practice of revascularization for claudication.
    2017 | PubMed
  143. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.
    2017 | PubMed
  144. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.
    2017 | PubMed
  145. Invited commentary.
    2017 | PubMed
  146. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.
    2017 | PubMed
  147. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage.
    2017 | PubMed
  148. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
    2017 | PubMed
  149. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
    2017 | PubMed
  150. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
    2016 | PubMed
  151. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes.
    2016 | PubMed
  152. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
    2016 | PubMed
  153. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
    2016 | PubMed
  154. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.
    2016 | PubMed
  155. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    2016 | PubMed
  156. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program.
    2016 | PubMed
  157. Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy.
    2016 | PubMed
  158. Critical Limb Ischemia: Current Trends and Future Directions.
    2016 | PubMed
  159. Predictors of major amputation despite patent bypass grafts.
    2016 | PubMed
  160. Nonrevascularization-based treatments in patients with severe or critical limb ischemia.
    2015 | PubMed
  161. The natural history of untreated severe or critical limb ischemia.
    2015 | PubMed
  162. Bypass surgery versus endovascular interventions in severe or critical limb ischemia.
    2015 | PubMed
  163. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
    2015 | PubMed
  164. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease.
    2015 | PubMed
  165. Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease.
    2015 | PubMed
  166. Revascularization for chronic limb-threatening ischaemia.
    2015 | PubMed
  167. Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study.
    2015 | PubMed
  168. Surgical intervention for peripheral arterial disease.
    2015 | PubMed
  169. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
    2015 | PubMed
  170. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
    2015 | PubMed
  171. Primary stenting in femoropopliteal occlusive disease - what is the appropriate role?
    2015 | PubMed
  172. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).
    2015 | PubMed
  173. A systematic review for the screening for peripheral arterial disease in asymptomatic patients.
    2015 | PubMed
  174. A systematic review of treatment of intermittent claudication in the lower extremities.
    2015 | PubMed
  175. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction.
    2015 | PubMed
  176. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    2015 | PubMed
  177. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service.
    2015 | PubMed
  178. Advancing beyond the "heart-healthy diet" for peripheral arterial disease.
    2015 | PubMed
  179. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells.
    2014 | PubMed
  180. Relationship between kidney disease and endothelial function in peripheral artery disease.
    2014 | PubMed
  181. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.
    2014 | PubMed
  182. Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease".
    2014 | PubMed
  183. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.
    2014 | PubMed
  184. Gender-specific risk factors for peripheral artery disease in a voluntary screening population.
    2014 | PubMed
  185. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.
    2014 | PubMed
  186. Short-term physical inactivity impairs vascular function.
    2014 | PubMed
  187. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
    2014 | PubMed
  188. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance.
    2013 | PubMed
  189. Growing impact of restenosis on the surgical treatment of peripheral arterial disease.
    2013 | PubMed
  190. Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.
    2013 | PubMed
  191. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).
    2013 | PubMed
  192. Vein graft failure.
    2013 | PubMed
  193. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
    2013 | PubMed
  194. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
    2013 | PubMed
  195. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    2013 | PubMed
  196. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.
    2013 | PubMed
  197. Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
    2013 | PubMed
  198. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.
    2013 | PubMed
  199. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.
    2013 | PubMed
  200. Critical appraisal of surgical revascularization for critical limb ischemia.
    2013 | PubMed
  201. Setting high-impact clinical research priorities for the Society for Vascular Surgery.
    2013 | PubMed
  202. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.
    2013 | PubMed
  203. Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules.
    2013 | PubMed
  204. Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.
    2012 | PubMed
  205. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.
    2012 | PubMed
  206. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.
    2012 | PubMed
  207. Medical management of peripheral arterial disease: bridging the "gap"?
    2012 | PubMed
  208. Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo.
    2012 | PubMed
  209. Clinical practice. Acute limb ischemia.
    2012 | PubMed
  210. Diabetic revascularization: endovascular versus open bypass--do we have the answer?
    2012 | PubMed
  211. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
    2012 | PubMed
  212. Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts.
    2012 | PubMed
  213. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.
    2012 | PubMed
  214. Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion.
    2012 | PubMed
  215. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.
    2012 | PubMed
  216. Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial.
    2012 | PubMed
  217. Polyunsaturated fatty acids and peripheral artery disease.
    2012 | PubMed
  218. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.
    2011 | PubMed
  219. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling.
    2011 | PubMed
  220. Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial".
    2011 | PubMed
  221. Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization.
    2011 | PubMed
  222. Assessing drug elution technologies in the superficial femoral artery.
    2011 | PubMed
  223. Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice.
    2011 | PubMed
  224. Discussion. Open surgical revascularization for wound healing: past performance and future directions; and Critical evaluation of endovascular surgery for limb salvage.
    2011 | PubMed
  225. Analysis of variables predictive of severity in biliary peritonitis.
    2010 | PubMed
  226. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease.
    2010 | PubMed
  227. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
    2010 | PubMed
  228. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
    2010 | PubMed
  229. Understanding objective performance goals for critical limb ischemia trials.
    2010 | PubMed
  230. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
    2010 | PubMed
  231. Shifting from open surgical cut down to ultrasound-guided percutaneous central venous catheterization in children: learning curve and related complications.
    2010 | PubMed
  232. Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index.
    2010 | PubMed
  233. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
    2010 | PubMed
  234. Critical limb ischemia.
    2010 | PubMed
  235. Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts.
    2010 | PubMed
  236. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    2010 | PubMed
  237. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.
    2009 | PubMed
  238. Surgical revascularization. Introduction.
    2009 | PubMed
  239. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes?
    2009 | PubMed
  240. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
    2009 | PubMed
  241. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
    2009 | PubMed
  242. In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE.
    2009 | PubMed
  243. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.
    2009 | PubMed
  244. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials.
    2009 | PubMed
  245. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.
    2009 | PubMed
  246. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage.
    2009 | PubMed
  247. Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair.
    2009 | PubMed
  248. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss.
    2008 | PubMed
  249. Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.
    2008 | PubMed
  250. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
    2008 | PubMed
  251. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures.
    2008 | PubMed
  252. Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures?
    2008 | PubMed
  253. C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.
    2008 | PubMed
  254. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.
    2008 | PubMed
  255. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
    2008 | PubMed
  256. High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE.
    2008 | PubMed
  257. Buflomedil in peripheral arterial disease: trials and tribulations.
    2008 | PubMed
  258. Clinical results of carotid artery stenting compared with carotid endarterectomy.
    2008 | PubMed
  259. Lower extremity vein graft failure: a translational approach.
    2008 | PubMed
  260. Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging.
    2007 | PubMed
  261. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia.
    2007 | PubMed
  262. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial.
    2007 | PubMed
  263. Regulation of vascular smooth muscle cell growth by survivin.
    2007 | PubMed
  264. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial.
    2007 | PubMed
  265. Molecular engineering of vein bypass grafts.
    2007 | PubMed
  266. Restenosis after carotid endarterectomy performed with routine intraoperative duplex ultrasonography and arterial patch closure: a contemporary series.
    2007 | PubMed
  267. Screening for cardiovascular risk factors in a dental setting.
    2007 | PubMed
  268. Superficial femoral artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts.
    2007 | PubMed
  269. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification.
    2007 | PubMed
  270. Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass.
    2007 | PubMed
  271. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.
    2006 | PubMed
  272. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.
    2006 | PubMed
  273. Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.
    2006 | PubMed
  274. Retroperitoneoscopic lumbar sympathectomy for nonreconstructable arterial occlusive disease.
    2006 | PubMed
  275. Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness.
    2006 | PubMed
  276. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia.
    2006 | PubMed
  277. Survivin regulation of vascular injury.
    2006 | PubMed
  278. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
    2006 | PubMed
  279. Lower-extremity arterial disease.
    2005 | PubMed
  280. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage.
    2005 | PubMed
  281. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
    2005 | PubMed
  282. Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.
    2005 | PubMed
  283. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype.
    2005 | PubMed
  284. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.
    2005 | PubMed
  285. Gene therapy for the extension of vein graft patency: a review.
    2005 | PubMed
  286. Infrainguinal vein bypass graft revision: factors affecting long-term outcome.
    2004 | PubMed
  287. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
    2004 | PubMed
  288. Carotid endarterectomy: who is the high-risk patient?
    2004 | PubMed
  289. Genetic therapy for vein bypass graft disease: current perspectives.
    2004 | PubMed
  290. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.
    2004 | PubMed
  291. Thoracovisceral segment aneurysm repair after previous infrarenal abdominal aortic aneurysm surgery.
    2004 | PubMed
  292. Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling.
    2004 | PubMed
  293. Primer extension assay for prion protein genotype determination in sheep.
    2004 | PubMed
  294. Animal transmissible spongiform encephalopathies and genetics.
    2003 | PubMed
  295. Preoperative risk factors for carotid endarterectomy: defining the patient at high risk.
    2003 | PubMed
  296. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting.
    2003 | PubMed
  297. Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm.
    2003 | PubMed
  298. Transcription factor decoys for the prevention of vein bypass graft failure.
    2003 | PubMed
  299. Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.
    2002 | PubMed
  300. Genetic interventions for vein bypass graft disease: a review.
    2002 | PubMed
  301. Transaortic endarterectomy for primary mesenteric revascularization.
    2002 | PubMed
  302. Inhibitor of apoptosis protein survivin regulates vascular injury.
    2002 | PubMed
  303. Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein.
    2002 | PubMed
  304. Initial experience with minimally invasive in situ bypass procedure with blind valvulotomy.
    2002 | PubMed
  305. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
    2002 | PubMed
  306. Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit.
    2002 | PubMed
  307. Usefulness of autogenous bypass grafts originating distal to the groin.
    2002 | PubMed
  308. Impact of harmonic scalpel on operative time during video-assisted thyroidectomy.
    2001 | PubMed
  309. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?
    2001 | PubMed
  310. Secondary aortoduodenal fistula.
    2001 | PubMed
  311. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries.
    2001 | PubMed
  312. Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes?
    2001 | PubMed
  313. Minimally invasive video-assisted thyroidectomy.
    2001 | PubMed
  314. Monocyte adhesion to balloon-injured arteries: the influence of endothelial cell seeding.
    2001 | PubMed
  315. Arterial reconstruction for lower limb ischemia.
    2001 | PubMed
  316. Impact of increasing comorbidity on infrainguinal reconstruction: a 20-year perspective.
    2001 | PubMed
  317. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction.
    2001 | PubMed
  318. Minimally invasive video-assisted parathyroidectomy: lesson learned from 137 cases.
    2000 | PubMed
  319. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    2000 | PubMed
  320. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
    2000 | PubMed
  321. Infrainguinal arterial reconstructions with vein grafts in patients with prior aortic procedures: the influence of aneurysm and occlusive disease.
    2000 | PubMed
  322. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    1999 | PubMed
  323. Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease.
    1999 | PubMed
  324. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence.
    1998 | PubMed
  325. Retroviral gene transfer: effects on endothelial cell phenotype.
    1998 | PubMed
  326. Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs.
    1998 | PubMed
  327. The ideal small arterial substitute: a search for the Holy Grail?
    1998 | PubMed
  328. [Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
    1997 | PubMed
  329. Effect of renal insufficiency on outcome following infrarenal aortic surgery.
    1997 | PubMed
  330. The impact of gender on the results of arterial bypass with in situ greater saphenous vein.
    1995 | PubMed
  331. Femorotibial bypass for claudication: do results justify an aggressive approach?
    1995 | PubMed
  332. Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury.
    1995 | PubMed
  333. Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries.
    1995 | PubMed
  334. Preferred strategies for secondary infrainguinal bypass: lessons learned from 300 consecutive reoperations.
    1995 | PubMed
  335. Endothelialization of prosthetic vascular grafts: current status and future directions.
    1995 | PubMed
  336. Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells.
    1994 | PubMed
  337. Percutaneous ultrasound-guided drainage of intra-abdominal abscesses.
    1993 | PubMed
  338. Repopulation of injured arteries with genetically modified endothelial cells.
    1992 | PubMed
  339. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts.
    1991 | PubMed
  340. Pseudofolliculitis barbae. No 'pseudoproblem'.
    1979 | PubMed
  341. [Intraparietal hematomas of the small intestine during anticoagulant treatment].
    1972 | PubMed
  342. A novel ergonomic simulator for laparoscopic surgery.
    2024 | PubMed
  343. Instrument and Supply Variability: An Opportunity to Reduce the Carbon Footprint of the Operating Room.
    2023 | PubMed
  344. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers.
    2023 | PubMed
  345. GPT-4: A Creative Copilot for Navigating Academic Surgery.
    2023 | PubMed
  346. Evaluation of a novel platform for placement confirmation of enteral feeding tubes in adults.
    2023 | PubMed
  347. The Unique Device Identifier: A Unique Opportunity
    2023 | UCSF Research Profile
  348. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia.
    2022 | PubMed
  349. The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement.
    2021 | PubMed
  350. Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center.
    2021 | PubMed
  351. Long-term Lower Extremity and Cardiovascular Complications after Simultaneous Pancreas-Kidney Transplant.
    2021 | PubMed
  352. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
    2020 | PubMed
  353. Antegrade common femoral artery closure device use is associated with decreased complications.
    2020 | PubMed
  354. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.
    2020 | PubMed
  355. Local versus global mechanical effects of intramural swelling in carotid arteries.
    2015 | PubMed